Works matching IS 00071188 AND DT 2025 AND VI 182 AND IP 3

Results: 17

A systematic assessment of robustness in CNS safety pharmacology.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 3, p. 530, doi. 10.1111/bph.17358

By:

Reiber, Maria;
Stirling, Helen;
Ahuis, Tim P.;
Arias, Washington;
Aulehner, Katharina;
Dreßler, Ute;
Kas, Martien J. H.;
Kela, Johanna;
Kerker, Kimberly;
Kuosmanen, Tarja;
Lorenz, Helga;
Pennington, Alexander T.;
von Rüden, Eva‐Lotta;
Schauerte, Heike;
Seiffert, Isabel;
Talbot, Steven R.;
Torturo, Christina;
Virtanen, Sami;
Waldron, Ann‐Marie;
Ramboz, Sylvie

Publication type:

Article

Beneficial effects of CHF6467, a modified human nerve growth factor, in experimental neonatal hypoxic–ischaemic encephalopathy.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 3, p. 510, doi. 10.1111/bph.17353

By:

Landucci, Elisa;
Mango, Dalila;
Carloni, Silvia;
Mazzantini, Costanza;
Pellegrini‐Giampietro, Domenico E.;
Saidi, Amira;
Balduini, Walter;
Schiavi, Elisa;
Tigli, Laura;
Pioselli, Barbara;
Imbimbo, Bruno P.;
Facchinetti, Fabrizio

Publication type:

Article

A novel hypothesis‐generating computational workflow utilizing reverse pharmacophore mapping—A drug repurposing perspective of istradefylline towards major depressive disorder.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 3, p. 596, doi. 10.1111/bph.17346

By:

van der Walt, Mietha Magdalena;
Smith, Arnold Petrus

Publication type:

Article

The activated caveolin‐3/μ‐opioid receptor complex drives morphine‐induced rescue therapy in failing hearts.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 3, p. 651, doi. 10.1111/bph.17326

By:

Guo, Chengxiao;
Pan, Xinxin;
Dou, Mengyun;
Wu, Juan;
Chen, Xinyu;
Wang, Baoli;
Zhu, Rui;
Xu, Shijin;
Peng, Wenyi;
Wu, Chao;
He, Shufang;
Zhang, Sihe;
Zhang, Ye;
Jin, Shiyun

Publication type:

Article

Gpr55 deficiency crucially alters cardiomyocyte homeostasis and counteracts angiotensin II induced maladaption in female mice.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 3, p. 670, doi. 10.1111/bph.17350

By:

Schopohl, Brigitte;
Kohlhaas, Michael;
Nickel, Alexander G.;
Schiuma, Anna‐Florentine;
Maas, Sanne L.;
van der Vorst, Emiel P. C.;
Shia, Yi Xuan;
Maack, Christoph;
Steffens, Sabine;
Puhl, Sarah‐Lena

Publication type:

Article

EXPRESSION OF CONCERN: Rosiglitazone and 15‐deoxy‐Δ12,14‐prostaglandin J2, ligands of the peroxisome proliferator‐activated receptor‐γ (PPAR‐γ), reduce ischaemia/reperfusion injury of the gut

Published in:: British Journal of Pharmacology, 2025, v. 182, n. 3, p. 925, doi. 10.1111/bph.17421
Publication type:: Article

Correction to "AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis".

Published in:: British Journal of Pharmacology, 2025, v. 182, n. 3, p. 924, doi. 10.1111/bph.17416
Publication type:: Article

Selected Abstracts from Pharmacology 2024.

Published in:: British Journal of Pharmacology, 2025, v. 182, n. 3, p. 692, doi. 10.1111/bph.17399
Publication type:: Article

Evidence generation throughout paediatric medicines life cycle: findings from collaborative work between European Medicines Agency (EMA) and EUnetHTA on use of extrapolation.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 3, p. 484, doi. 10.1111/bph.17396

By:

Karres, Dominik;
Pino‐Barrio, María José;
Benchetrit, Sylvie;
Benda, Norbert;
Cochat, Pierre;
Galluzzo, Sara;
García‐Solís, Alejandro;
Gonzalez, Sara;
de Lisa, Roberto;
Khan, David;
Lankester, Rita;
Lentz, Frederike;
Martínez‐Ortega, Pilar Angustias;
Montilla, Simona;
Morales, Daniel R.;
Tshinanu, Flora Musuamba;
Sánchez, Sonia Pulido;
Montero, Ana Rossignoli;
Scherer, Sabine;
Thomson, Andrew

Publication type:

Article

GraphCPP: The new state‐of‐the‐art method for cell‐penetrating peptide prediction via graph neural networks.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 3, p. 495, doi. 10.1111/bph.17388

By:

Imre, Attila;
Balogh, Balázs;
Mándity, István

Publication type:

Article

Development of new Kir2.1 channel openers from propafenone analogues.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 3, p. 633, doi. 10.1111/bph.17377

By:

Li, Encan;
Boujeddaine, Najla;
Houtman, Marien J. C.;
Maas, Renee G. C.;
Sluijter, Joost P. G.;
Ecker, Gerhard F.;
Stary‐Weinzinger, Anna;
van Ham, Willem B.;
van der Heyden, Marcel A. G.

Publication type:

Article

Excitation–contraction coupling inhibitors potentiate the actions of botulinum neurotoxin type A at the neuromuscular junction.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 3, p. 564, doi. 10.1111/bph.17367

By:

Machicoane, Mickaël;
Tonellato, Marika;
Zainotto, Marica;
Onillon, Paul;
Stazi, Marco;
Corso, Mattia Dal;
Megighian, Aram;
Rossetto, Ornella;
Le Doussal, Jean‐Marc;
Pirazzini, Marco

Publication type:

Article

tiRNA‐Gly‐GCC‐002 promotes epithelial‐mesenchymal transition and fibrosis in lupus nephritis via FKBP5‐mediated activation of Smad.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 3, p. 616, doi. 10.1111/bph.17364

By:

Liu, Xueting;
Zhang, Ji;
Liang, Yan;
Chen, Xuanwen;
Xu, Shungang;
Lin, Sishi;
Dai, Yuanting;
Chen, Xinxin;
Zhou, Ying;
Bai, Yongheng;
Chen, Chaosheng

Publication type:

Article

A pH‐sensitive opioid does not exhibit analgesic tolerance in a mouse model of colonic inflammation.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 3, p. 581, doi. 10.1111/bph.17363

By:

Degro, Claudius E.;
Jiménez‐Vargas, Nestor Nivardo;
Guzman‐Rodriguez, Mabel;
Schincariol, Hailey;
Tsang, Quentin;
Reed, David E.;
Lomax, Alan E.;
Bunnett, Nigel W.;
Stein, Christoph;
Vanner, Stephen J.

Publication type:

Article

Early transtympanic administration of rhBDNF exerts a multifaceted neuroprotective effect against cisplatin‐induced hearing loss.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 3, p. 546, doi. 10.1111/bph.17359

By:

Pisani, Anna;
Rolesi, Rolando;
Mohamed‐Hizam, Veronica;
Montuoro, Raffaele;
Paludetti, Gaetano;
Giorgio, Cristina;
Cocchiaro, Pasquale;
Brandolini, Laura;
Detta, Nicola;
Sirico, Anna;
Amendola, Pier Giorgio;
Novelli, Rubina;
Aramini, Andrea;
Allegretti, Marcello;
Paciello, Fabiola;
Grassi, Claudio;
Fetoni, Anna Rita

Publication type:

Article

Issue Information.

Published in:: British Journal of Pharmacology, 2025, v. 182, n. 3, p. 469, doi. 10.1111/bph.16444
Publication type:: Article

Role of 5‐HT in the enteric nervous system and enteroendocrine cells.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 3, p. 471, doi. 10.1111/bph.15930

By:

Spencer, Nick J.;
Keating, Damien J.

Publication type:

Article

Works matching IS 00071188 AND DT 2025 AND VI 182 AND IP 3

A systematic assessment of robustness in CNS safety pharmacology.

Beneficial effects of CHF6467, a modified human nerve growth factor, in experimental neonatal hypoxic–ischaemic encephalopathy.

A novel hypothesis‐generating computational workflow utilizing reverse pharmacophore mapping—A drug repurposing perspective of istradefylline towards major depressive disorder.

The activated caveolin‐3/μ‐opioid receptor complex drives morphine‐induced rescue therapy in failing hearts.

Gpr55 deficiency crucially alters cardiomyocyte homeostasis and counteracts angiotensin II induced maladaption in female mice.

EXPRESSION OF CONCERN: Rosiglitazone and 15‐deoxy‐Δ<sup>12,14</sup>‐prostaglandin J<sub>2</sub>, ligands of the peroxisome proliferator‐activated receptor‐γ (PPAR‐γ), reduce ischaemia/reperfusion injury of the gut

Correction to "AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis".

Selected Abstracts from Pharmacology 2024.

Evidence generation throughout paediatric medicines life cycle: findings from collaborative work between European Medicines Agency (EMA) and EUnetHTA on use of extrapolation.

GraphCPP: The new state‐of‐the‐art method for cell‐penetrating peptide prediction via graph neural networks.

Development of new K<sub>ir</sub>2.1 channel openers from propafenone analogues.

Excitation–contraction coupling inhibitors potentiate the actions of botulinum neurotoxin type A at the neuromuscular junction.

tiRNA‐Gly‐GCC‐002 promotes epithelial‐mesenchymal transition and fibrosis in lupus nephritis via FKBP5‐mediated activation of Smad.

A pH‐sensitive opioid does not exhibit analgesic tolerance in a mouse model of colonic inflammation.

Early transtympanic administration of rhBDNF exerts a multifaceted neuroprotective effect against cisplatin‐induced hearing loss.

Issue Information.

Role of 5‐HT in the enteric nervous system and enteroendocrine cells.